2m 2m 2m 2m 2m 2m 2m
LONGEVERON-A (LGVN)
NASDAQ
$2.57-$0.02 (-0.97%)
Price as of Oct 02, 2026 7:30 PM EDT- $7.9MMarket Cap
- -66.15%1-Year Change
- BiotechnologyIndustry
LONGEVERON-A (LGVN)
$2.57-$0.02 (-0.97%)
LGVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.59 | ||
Change | -$0.10 (-3.72%) | ||
Open | $2.72 | ||
High | $2.74 | ||
Low | $2.52 | ||
Previous Close | $2.69 | ||
Volume | 72,955 | ||
30-Day Average Volume | 169,586 | ||
1-Week Change | -11.00% | ||
1-Month Change | -61.63% | ||
1-Year Change | -66.15% | ||
3-Year Change | -98.89% | ||
5-Year Change | -99.29% | ||
Fundamentals | |||
Shares Outstanding | 3.0M | ||
Total Assets | $15.5M | ||
Market Cap | $7.9M | ||
Enterprise Value | -$2.2M | ||
Period: QTR TTM FY | |||
Revenue | $287,000.00 | ||
Net Income | -$6.1M | ||
Free Cash Flow | -$5.8M | ||
EBIT | -$6.1M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $7.0M | ||
EPS | -$1.90 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -8 | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/27/2026 | ||
Earnings & Revenue